IL95250A - 1-) Pyridinylamino (-2-pyrolidinones, a process for their preparation and use as drugs - Google Patents

1-) Pyridinylamino (-2-pyrolidinones, a process for their preparation and use as drugs

Info

Publication number
IL95250A
IL95250A IL9525090A IL9525090A IL95250A IL 95250 A IL95250 A IL 95250A IL 9525090 A IL9525090 A IL 9525090A IL 9525090 A IL9525090 A IL 9525090A IL 95250 A IL95250 A IL 95250A
Authority
IL
Israel
Prior art keywords
hydrogen
compound
loweralkyl
pyrrolidinone
pyridinylamino
Prior art date
Application number
IL9525090A
Other languages
English (en)
Hebrew (he)
Other versions
IL95250A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL95250A0 publication Critical patent/IL95250A0/xx
Publication of IL95250A publication Critical patent/IL95250A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9525090A 1989-08-02 1990-07-31 1-) Pyridinylamino (-2-pyrolidinones, a process for their preparation and use as drugs IL95250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,413 US4994472A (en) 1989-08-02 1989-08-02 1-(pyridinylamino)-2-pyrrolidinones as pain relievers

Publications (2)

Publication Number Publication Date
IL95250A0 IL95250A0 (en) 1991-06-10
IL95250A true IL95250A (en) 1994-01-25

Family

ID=23534027

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9525090A IL95250A (en) 1989-08-02 1990-07-31 1-) Pyridinylamino (-2-pyrolidinones, a process for their preparation and use as drugs

Country Status (17)

Country Link
US (1) US4994472A (de)
EP (1) EP0413191B1 (de)
JP (1) JPH0674264B2 (de)
KR (1) KR0164437B1 (de)
AT (1) ATE109142T1 (de)
AU (1) AU635051B2 (de)
CA (1) CA2022484C (de)
DE (1) DE69011013T2 (de)
DK (1) DK0413191T3 (de)
ES (1) ES2059929T3 (de)
FI (1) FI903818A0 (de)
IE (1) IE65117B1 (de)
IL (1) IL95250A (de)
NO (1) NO903388L (de)
NZ (1) NZ234724A (de)
PT (1) PT94878B (de)
ZA (1) ZA906049B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356908A (en) * 1989-04-21 1994-10-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
PE28391A1 (es) * 1989-12-27 1991-10-18 Monsanto Co Compuestos de piridina sustituidos
AUPM656594A0 (en) * 1994-06-30 1994-07-21 Orbital Engine Company (Australia) Proprietary Limited A method and apparatus relating to control of the operation of an internal combustion engine
IL126308A0 (en) * 1996-04-12 1999-05-09 Hoechst Marion Roussel Inc Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
WO2004004641A2 (en) * 2002-07-02 2004-01-15 Blanchette Rockefeller Neurosciences Institute PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS
TW201207390A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Method for screening agent for antidepressant activity
GB0412019D0 (en) * 2004-05-28 2004-06-30 Novartis Ag Organic compounds
EP1915145A1 (de) 2005-07-29 2008-04-30 Blanchette Rockefeller Neurosciences Institute Verwendung eines pkc-aktivators, allein oder in kombination mit einem pkc-hemmer zur verbesserung des langzeitgedächtnisses
EP3332797A3 (de) 2007-02-09 2018-08-01 Blanchette Rockefeller Neurosciences Institute Therapeutische wirkungen von bryostatinen, bryologen und anderen damit zusammenhängenden substanzen auf durch kopftraumata herbeigeführte gedächtnisstörungen und hirnverletzungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670184A1 (de) * 1967-01-20 1971-01-21 Boehringer Sohn Ingelheim Verfahren zur Herstellung heterocyclisch substituierter Hydrazino-imidazoline-(2)
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4324884A (en) * 1980-09-25 1982-04-13 General Electric Company Organic amine catalyzed method for making polyetherimide
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
JPH0699307B2 (ja) * 1987-08-20 1994-12-07 キッセイ薬品工業株式会社 抗痴呆剤
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines

Also Published As

Publication number Publication date
IL95250A0 (en) 1991-06-10
ATE109142T1 (de) 1994-08-15
IE902786A1 (en) 1991-02-27
EP0413191B1 (de) 1994-07-27
ZA906049B (en) 1991-04-24
CA2022484A1 (en) 1991-02-03
AU6000290A (en) 1991-02-07
DE69011013T2 (de) 1994-12-22
JPH0368572A (ja) 1991-03-25
KR0164437B1 (ko) 1999-01-15
CA2022484C (en) 2000-10-17
FI903818A0 (fi) 1990-07-31
KR910004597A (ko) 1991-03-29
IE65117B1 (en) 1995-10-04
DK0413191T3 (da) 1994-10-24
NO903388L (no) 1991-02-04
NZ234724A (en) 1992-01-29
NO903388D0 (no) 1990-08-01
PT94878B (pt) 1997-08-29
ES2059929T3 (es) 1994-11-16
AU635051B2 (en) 1993-03-11
US4994472A (en) 1991-02-19
EP0413191A1 (de) 1991-02-20
PT94878A (pt) 1991-04-18
DE69011013D1 (de) 1994-09-01
JPH0674264B2 (ja) 1994-09-21

Similar Documents

Publication Publication Date Title
FI91401B (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
EP0415102B1 (de) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0892796B1 (de) Isatinderivate als acetylcholinesterase-inhibitoren und analgetika
IL95250A (en) 1-) Pyridinylamino (-2-pyrolidinones, a process for their preparation and use as drugs
EP0415103B1 (de) 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
EP0376155A1 (de) N-Pyridinyl-9H-carbazol-9-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
KR100191386B1 (ko) 3-(1,2-벤즈이속사졸-3-일)-4-피리딘아민 및 유도체,이를 함유하는 약제학적 조성물 및 이의 제조방법
US5179099A (en) 2,3-dihydro-1-(pyridinylamino)-indoles
US5296488A (en) Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
US5216017A (en) Pyrrolo[2,3-b]indole-ketones and analogs
US5686626A (en) 1,3-dihydro-1-amino-2H-indol-2-ones
EP0456196A1 (de) Pyrrolo(2,3-b)indol-ketone und Analoge, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU716997C (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
RH Patent void
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
KB Patent renewed